Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus, a member of the Betacoronavirus genus, and the causative agent of COVID-19.1,2,3 The SARS-CoV-2 genome contains approximately 30 kilobases and 14 open reading frames (ORFs) that encode four structural proteins: spike, envelope, membrane, and nucleocapsid, as well as 16 non-structural proteins and nine accessory factors.4 SARS-CoV-2 non-structural protein 4 (nsp4) is encoded within ORF1ab and is involved in host cell membrane reorganization via the formation of endoplasmic reticulum-derived double-membrane vesicles (DMVs), which act as replication organelles.4,5 Ectopic expression of SARS-CoV-2 nsp4 induces the unfolded protein response (UPR), increases the production of mitochondrial reactive oxygen species (mtROS), and decreases the mitochondrial membrane potential in, as well as induces mitochondrial DNA (mtDNA) release from, host cells in vitro.6,7 A tyrosine-to-isoleucine mutation at position 492 in nsp4 (nsp4T492I) is present in several SARS-CoV-2 variants, including Delta and Omicron, increases viral infectivity and the cleavage efficiency of main protease (Mpro), also known as 3C-like protease (3CLpro), enhances evasion of the host immune response, and is associated with decreased disease severity.8
WARNING This product is not for human or veterinary use.
1. From SARS and MERS CoVs to SARS-
2. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395(10224), 565-574 (2020).
3. Novel coronavirus 2019-
4. A structural view of SARS-
5. SARS-
6. Expression of SARS-
7. NSP4 and ORF9b of SARS-
8. The NSP4 T492I mutation increases SARS-